1
Buprenorphine vs Buprenorphine/Naloxone on the Effects of Maternal Symptomatology
Condition(s):Opioid-use DisorderLast Updated:November 9, 2018Recruiting
SEARCH[Study] TILT[Study:StudyFirstPostDate] AREA[InterventionSearch] Buprenorphine as an Intervention: 516 Clinical Trials, Page 1 of 6
Hide Studies Not Open or Pending
2
An Open-Label Pilot Study of Sublocade as Treatment for Opiate Use Disorder
Condition(s):Opioid-use DisorderLast Updated:March 5, 2019Recruiting
3
Buprenorphine Pharmacometric Open Label Research Study of Drug Exposure
Condition(s):Neonatal Abstinence Syndrome; Neonatal Opiate Withdrawal SyndromeLast Updated:July 11, 2019Completed
4
Fetal and Infant Effects of Maternal Buprenorphine Treatment
Condition(s):Neonatal Abstinence SyndromeLast Updated:August 28, 2017Completed
5
SUBLOCADE Rapid Initiation Study
Condition(s):Opioid-use DisorderLast Updated:September 5, 2019Recruiting
6
New Application of Buprenorphine Patch on Painful Knee Joint in Knee Osteoarthritis Patients
Condition(s):Knee OsteoarthritisLast Updated:May 10, 2019Not yet recruiting
7
Bariatric Surgery and Pharmacokinetics of Buprenorphine
Condition(s):Obesity, MorbidLast Updated:March 6, 2019Recruiting
8
Buprenorphine Treatment for Opioid Dependence
Condition(s):Opioid DependenceLast Updated:September 4, 2018Recruiting
9
Assessing the Safety of Buprenorphine in People With Sickle Cell Disease
Condition(s):Sickle Cell DiseaseLast Updated:June 11, 2019Enrolling by invitation
10
SUBLOCADE Rapid Initiation Extension Study
Condition(s):Opioid Use Disorder, Severe; Opioid Use Disorder, ModerateLast Updated:August 16, 2019Not yet recruiting
11
Buprenorphine Group Medical Visits in Primary Care
Condition(s):Opioid-Related DisordersLast Updated:August 16, 2019Completed
12
Pharmacokinetics, Safety, and Efficacy of Intravenous Dosing of Buprenorphine in Pediatric Patients Who Require Opioid Analgesia for Acute Moderate to Severe Pain
Condition(s):Other Acute Postoperative Pain; Prolonged Endotracheal IntubationLast Updated:February 3, 2016Withdrawn
13
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Low Back Pain
Condition(s):Pain; Low Back PainLast Updated:April 16, 2012Withdrawn
14
Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
Condition(s):Pain; Low Back Pain; Osteoarthritis; Neuropathic PainLast Updated:August 5, 2018Completed
15
Feasibility of the Utilization of Buprenorphine in the Emergency Room to Treat Clinical Opioid Withdrawal
Condition(s):Drug Overdose; Opioid Withdrawal; Opioid-use DisorderLast Updated:December 12, 2018Completed
16
Study Assessing the Safety and Therapeutic Effect of Buprenorphine in MDD Patients
Condition(s):DepressionLast Updated:September 23, 2012Unknown status
17
Incomplete Response in Late-Life Depression: Getting to Remission With Buprenorphine
Condition(s):Depression; Major Depressive DisorderLast Updated:August 1, 2018Completed
18
Phase II Pharmacokinetics Study of CAM2038
Condition(s):Opioid Use Disorder; Chronic PainLast Updated:October 7, 2016Unknown status
19
Buprenorphine for Late-Life Treatment Resistant Depression
Condition(s):DepressionLast Updated:February 9, 2018Completed
20
Buprenorphine for Treatment Resistant Depression
Condition(s):Depression; Depressive Disorder; Depressive Disorder, MajorLast Updated:February 9, 2018Completed
21
A Prospective, Randomized Trial of the Effect of Standard of Care Reduced Dose Versus Full Dose Buprenorphine/Naloxone in the Perioperative Period on Pain Control and Post-Operative Opioid Use Disorder Symptoms
Condition(s):Opioid-use Disorder; Opioid Use Disorder, MildLast Updated:September 13, 2019Not yet recruiting
22
Buprenorphine in the Emergency Department
Condition(s):Opioid Withdrawal; Opioid-use DisorderLast Updated:May 30, 2017Completed
23
Safety of Buprenorphine Transdermal Systems in Subjects With Chronic Nonmalignant Pain – a 28-week Extension Study
Condition(s):Chronic Nonmalignant PainLast Updated:September 5, 2012Completed
24
Effect of Buprenorphine/Naloxone Continuation on Pain Control and Opioid Use
Condition(s):Opioid-use Disorder; Pain, Acute; SurgeryLast Updated:October 5, 2018Not yet recruiting
25
Buprenorphine Stabilization and Induction Onto Vivitrol for Heroin-dependent Individuals
Condition(s):Heroin DependenceLast Updated:December 13, 2018Recruiting
26
CBT4CBT for Office Based Buprenorphine
Condition(s):Opioid-use DisorderLast Updated:January 29, 2019Recruiting
27
HIV, Buprenorphine, and the Criminal Justice System (STRIDE2)
Condition(s):Human Immunodeficiency Virus; Acquired Immunodeficiency Syndrome; Opiate Addiction; Drug DependenceLast Updated:June 26, 2018Completed
28
Long-Term Safety Study of Buprenorphine (CAM2038) in Adult Outpatients With Opioid Use Disorder
Condition(s):Opioid Use DisorderLast Updated:July 8, 2019Completed
29
Interim Buprenorphine Treatment to Bridge Waitlist Delays: Stage II Evaluation
Condition(s):Opioid-use DisorderLast Updated:May 1, 2019Recruiting
30
The Safety of Using Buprenorphine With Naloxone in a Buccal Film to Initiate Treatment of Opioid Dependent Subjects
Condition(s):Opioid DependenceLast Updated:May 2, 2017Withdrawn
31
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
Condition(s):PainLast Updated:June 7, 2017Completed
32
Effects of Low Dose Buprenorphine on Recovery After Hip or Knee Arthroplasty
Condition(s):Pain; OsteoarthritisLast Updated:December 25, 2015Completed
33
Preference for Subutex® (Buprenorphine) Versus Suboxone® (Buprenorphine/Naloxone) in Opioid Dependent Patients on Subutex® (Study P05094)(COMPLETED)
Condition(s):Opiate-related Disorders; Opiate Dependence; Drug AbuseLast Updated:April 14, 2011Completed
34
XRB vs. SLB in Jail and at Re-entry: Pilot, Proof of Concept
Condition(s):Opioid DependenceLast Updated:April 4, 2019Not yet recruiting
35
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
Condition(s):Chronic Lower Back Pain; Chronic PainLast Updated:July 16, 2018Active, not recruiting
36
Long Acting Buprenorphine Injection Compared to Sublingual Buprenorphine/Naloxone Films
Condition(s):Opioid UseLast Updated:October 7, 2019Not yet recruiting
37
Transfer From Methadone to Buprenorphine Maintenance Treatment Using Buprenorphine Patches
Condition(s):Heroin AddictionLast Updated:September 9, 2008Unknown status
38
Buprenorphine Treatment: A Safe Alternative for Opioid Dependent Pain Patients
Condition(s):Opioid Use DisorderLast Updated:March 23, 2018Terminated
39
Buprenorphine Dose Adjustments and Gestational Age
Condition(s):Neonatal Abstinence SyndromeLast Updated:November 17, 2017Completed
40
Disposition Effects of Cyclosporin on Buprenorphine
Condition(s):HealthyLast Updated:November 21, 2017Completed
41
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects
Condition(s):Opioid DependenceLast Updated:February 13, 2017Completed
42
Buprenorphine for the Treatment of Neonatal Abstinence Syndrome
Condition(s):Neonatal Abstinence SyndromeLast Updated:January 11, 2017Completed
43
Buprenorphine/Naloxone Stabilization and Induction Onto Injection Naltrexone
Condition(s):Opioid DependenceLast Updated:October 30, 2018Completed
44
Multiple Dose Pharmacokinetics Depot Buprenorphine in Opioid-Dependent Subjects
Condition(s):Opioid Related DisorderLast Updated:January 26, 2018Completed
45
Pharmacologically-based Strategies for Buprenorphine Treatment During Pregnancy
Condition(s):Opiate Addiction; PregnancyLast Updated:August 29, 2019Recruiting
46
Study of Two Formulations of Buprenorphine HCl in Opioid-dependent Subjects on Buprenorphine Maintenance Therapy (Study P04451) (COMPLETED)
Condition(s):Opioid DependencyLast Updated:April 14, 2011Completed
47
Add-on Buprenorphine at Analgesic Doses for the Treatment of Severe Suicidal Ideas During a Major Depressive Episode
Condition(s):Suicidal Ideation; Major Depressive EpisodeLast Updated:September 27, 2019Not yet recruiting
48
Buprenorphine 8 mg Sublingual Tablets Under Fasting Conditions
Condition(s):HealthyLast Updated:November 22, 2010Completed
49
Buprenorphine for Treatment of Neonatal Abstinence Syndrome in Infants With In Utero Exposure to Benzodiazepines
Condition(s):Neonatal Abstinence SyndromeLast Updated:October 13, 2016Completed
50
Medication Treatment for Opioid Use Disorder in Expectant Mothers
Condition(s):Opioid-Related Disorders; Drug Addiction; Pregnancy Related; Substance Abuse; Drug Abuse; Neonatal Abstinence Syndrome; Neonatal Opioid Withdrawal Syndrome; Drug Abuse in PregnancyLast Updated:September 24, 2019Not yet recruiting
51
An Interventional Study to Assess the Efficacy and Safety of Buprenorphine in Korean Patients With Spinal Disorders
Condition(s):Spinal DisorderLast Updated:October 1, 2015Completed
52
Medication Treatment for Opioid Use Disorder in Expectant Mothers: Conceptual Model Assessments Sub-study
Condition(s):Opioid-Related Disorders; Drug Addiction; Pregnancy Related; Substance Abuse; Drug Abuse; Neonatal Abstinence Syndrome; Neonatal Opioid Withdrawal Syndrome; Drug Abuse in PregnancyLast Updated:September 24, 2019Not yet recruiting
53
Study of a Novel Subcutaneous Depot Formulation of Buprenorphine
Condition(s):Opioid-use DisorderLast Updated:March 1, 2019Completed
54
Comparison of Buprenorphine to Morphine in Treatment of Neonatal Abstinence Syndrome (NAS)
Condition(s):Neonatal Abstinence Syndrome; Neonatal Withdrawal SyndromeLast Updated:August 14, 2018Completed
55
Examine Plasma Concentrations of Buprenorphine Following Reapplication of Buprenorphine Transdermal System (BTDS) After Variable Application Site Rest Periods
Condition(s):HealthyLast Updated:August 27, 2012Completed
56
Intravenous Buprenorphine Versus Morphine for Severe Pain in the Emergency Department
Condition(s):PainLast Updated:October 17, 2017Unknown status
57
Effectiveness of Buprenorphine/Naloxone in Reducing Intravenous Buprenorphine Misuse in France (“RIME”)
Condition(s):Opioid DependencyLast Updated:November 28, 2012Completed
58
Effects of Buprenorphine on Mood in Adults With a Range of Depressive Symptomatology
Condition(s):DepressionLast Updated:May 6, 2019Completed
59
Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Nonmalignant Pain
Condition(s):Chronic Non-malignant PainLast Updated:September 5, 2012Completed
60
Postoperative Analgesia With Buprenorphine for Postoperative Pain Control and Quality of Life After Spinal Surgery
Condition(s):Spinal Stenosis; Pain, PostoperativeLast Updated:May 2, 2017Completed
61
Blinded Trial of Buprenorphine or Morphine in the Treatment of the Neonatal Abstinence Syndrome
Condition(s):Neonatal Abstinence SyndromeLast Updated:February 3, 2017Completed
62
Study to Assess Efficacy and Safety of BNX Sublingual Tablets for the Induction of Treatment of Opioid Dependence
Condition(s):Opioid-Related Disorders; Opiate DependenceLast Updated:April 3, 2017Completed
63
Integrating Buprenorphine Into the SFGH AIDS Program
Condition(s):HIV; Buprenorphine; Opioid DependenceLast Updated:September 8, 2011Completed
64
Buprenorphine Used With Treatment Resistant Depression in Older Adults
Condition(s):Major Depressive Disorder; DepressionLast Updated:June 3, 2019Completed
65
Buprenorphine Physician-Pharmacist Collaboration in the Management of Patients With Opioid Use Disorder: CTN 0075
Condition(s):Opioid Use DisorderLast Updated:July 11, 2019Completed
66
Efficacy of Buprenorphine for Treatment of Acute Pain
Condition(s):Acute PainLast Updated:December 6, 2012Completed
67
Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Experienced Subjects
Condition(s):Low Back PainLast Updated:January 12, 2017Completed
68
Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Naive Subjects
Condition(s):Low Back PainLast Updated:January 12, 2017Completed
69
Induction of Opioid-Dependent Individuals Onto Buprenorphine and Buprenorphine/Naloxone
Condition(s):Opioid-related DisordersLast Updated:April 24, 2017Completed
70
Efficacy and Safety Study of Buprenorphine HCl Buccal Film in Subjects With Low Back Pain
Condition(s):Pain; Low Back PainLast Updated:January 12, 2017Completed
71
Observational Study of Misuse of High Dose Buprenorphine (Subutex® or Generic) in Opiate-Addicted Patients in France (Study P05186AM1)(COMPLETED)
Condition(s):Buprenorphine; Naloxone; Opiate-related Disorders; Opiate Dependence; Drug AbuseLast Updated:April 14, 2011Completed
72
Study of Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain
Condition(s):PainLast Updated:August 3, 2017Completed
73
The Effects of Buprenorphine on Responses to Verbal Tasks
Condition(s):Basic ScienceLast Updated:May 30, 2019Completed
74
Butrans for Treatment of Restless Legs Syndrome
Condition(s):Restless Legs SyndromeLast Updated:January 6, 2015Withdrawn
75
Buprenorphine in the Treatment of Osteoarthritis (OA) in the Elderly
Condition(s):OsteoarthritisLast Updated:June 13, 2011Completed
76
Interim Buprenorphine: Leveraging Medication + Technology to Bridge Delays in Treatment Access
Condition(s):Opioid-related DisordersLast Updated:April 30, 2018Completed
77
Study to Evaluate the Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenorphine Dose Reduction
Condition(s):Substance Withdrawal Syndrome; Opiate Addiction; Opiate DependenceLast Updated:October 24, 2017Completed
78
Pupillometry and Pain Thresholds Patients Substituted by Methadone and Buprenorphine
Condition(s):Opiate Dependent; Previous Illicit Drug UseLast Updated:January 11, 2013Unknown status
79
Effects of Gabapentin Versus Placebo on Buprenorphine Detoxification of Opioid-dependent Individuals
Condition(s):Opioid Dependence; Opioid Withdrawal; Opioid DetoxificationLast Updated:June 19, 2013Completed
80
Incomplete Response in Late-Life Depression: Getting to Remission With Buprenorphine
Condition(s):Major Depressive Disorder; DepressionLast Updated:July 24, 2018Completed
81
Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment
Condition(s):Opioid Use DisorderLast Updated:June 5, 2018Completed
82
Neuroimaging Study on the Effect of Transdermal Buprenorphine in Complex Regional Pain Syndrome Patients
Condition(s):Complex Regional Pain SyndromesLast Updated:September 17, 2019Recruiting
83
A Bioavailability and Safety Study of Probuphine Versus Sublingual Buprenorphine in Patients With Opioid Dependence
Condition(s):Opioid DependenceLast Updated:December 27, 2018Terminated
84
Pilot Test of a Community-based Buprenorphine Treatment Intervention
Condition(s):Opioid Dependence; Injection Drug UseLast Updated:April 19, 2018Completed
85
Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain
Condition(s):Post-operative PainLast Updated:August 3, 2017Terminated
86
Buprenorphine Transdermal Patch in Subjects With Osteoarthritis Pain Requiring Opioids. Includes a 52-Week Safety Extension.
Condition(s):OsteoarthritisLast Updated:August 27, 2012Terminated
87
Safety and Efficacy of Dose Conversion From Vicodin® to Buprenorphine Transdermal System (Butrans™) in Subjects With OA Pain
Condition(s):OsteoarthritisLast Updated:August 27, 2012Completed
88
Safety and Efficacy of Buprenorphine Transdermal System in Subjects With Moderate to Severe Osteoarthritis of Hip or Knee
Condition(s):OsteoarthritisLast Updated:August 27, 2012Completed
89
Buprenorphine Transdermal Patches in Arthroscopic Rotator Cuff Repair
Condition(s):Rotator Cuff Tear; Rotator Cuff Injury; Analgesics, Opioid; BuprenorphineLast Updated:January 28, 2019Recruiting
90
Bioequivalency Study of Buprenorphine Hydrochloride 8 mg Tablet Under Fasted Conditions
Condition(s):Opioid-Related DisordersLast Updated:January 19, 2018Completed
91
Pharmacokinetics, Safety, and Tolerability of Depot Buprenorphine at Three Different Molecular Weights in Treatment-Seeking Subjects With Opioid Use Disorder
Condition(s):Opioid Use DisorderLast Updated:January 30, 2017Completed
92
Re-Treatment Study of Probuphine in Opioid Addiction
Condition(s):Opioid DependencyLast Updated:December 27, 2018Completed
93
Efficacy and Safety of Buprenorphine Transdermal Patch in Non-cancer Pain of Moderate Intensity
Condition(s):Osteoarthritis; Rheumatoid Arthritis; Lower Back Pain; Joint Pain; Muscle PainLast Updated:July 14, 2016Completed
94
Sublingual Buprenorphine for Chronic Pain
Condition(s):Chronic PainLast Updated:April 6, 2009Unknown status
95
A Strategy to Improve Success of Treatment Discontinuation in Buprenorphine Responders
Condition(s):Opioid-use DisorderLast Updated:October 11, 2018Recruiting
96
Study of Probuphine in Patients With Opioid Dependence
Condition(s):Opioid DependencyLast Updated:December 27, 2018Terminated
97
Multiple Dose Study of Blockade of Opioid Effects by Injections of Buprenorphine in Participants With Opioid Disorder
Condition(s):Opioid Use DisorderLast Updated:April 23, 2018Completed
98
Buprenorphine Transdermal Patches (BTDS) in Subjects With Osteoarthritis Pain. Includes a 52-week Extension Phase.
Condition(s):OsteoarthritisLast Updated:August 27, 2012Terminated
99
Extension to Safety and Efficacy of Probuphine in the Treatment of Opioid Dependence
Condition(s):Opioid DependenceLast Updated:December 27, 2018Completed
100
Bioequivalence and Adhesion Comparison of Buprenorphine Patches
Condition(s):PainLast Updated:February 8, 2016Completed